Compare PBAM & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBAM | SOPH |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.4M | 462.3M |
| IPO Year | 2017 | 2021 |
| Metric | PBAM | SOPH |
|---|---|---|
| Price | $85.35 | $7.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $99.75 | $9.75 |
| AVG Volume (30 Days) | 98.3K | ★ 570.1K |
| Earning Date | 01-15-2027 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.32 | $23.24 |
| Revenue Next Year | $7.69 | $24.63 |
| P/E Ratio | $19.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $81.85 | $3.83 |
| 52 Week High | $92.09 | $8.98 |
| Indicator | PBAM | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 54.12 |
| Support Level | $83.95 | $7.71 |
| Resistance Level | $87.30 | $7.88 |
| Average True Range (ATR) | 1.74 | 0.45 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 51.48 | 91.72 |
Private Bancorp of America Inc is a commercial bank chartered by the State of California. It provides comprehensive banking services, including deposit accounts, treasury management services, and lending solutions tailored to high-net-worth individuals, professionals, family offices, closely-held businesses, real estate entrepreneurs, and small to mid-sized businesses. Lending activities include commercial real estate loans, commercial and industrial loans, and government-guaranteed lending programs.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.